Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Intellia Therapeutics
NTLA
$1.57B
| $5.55M | ﹤0.01% |
780,224
-7,266
| -0.9% | -$73.4K |
|
2227
Acco Brands
ACCO
$407M
| $5.53M | ﹤0.01% |
1,320,507
+102,076
| +8% | +$501K |
|
2228
Central Garden & Pet Co
CENT
$2.91B
| $5.51M | ﹤0.01% |
150,427
+12,154
| +9% | +$445K |
|
2229
ZTO Express
ZTO
$18.3B
| $5.51M | ﹤0.01% |
277,921
+1,495
| +0.5% | +$29.2K |
|
2230
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.08B
| $5.51M | ﹤0.01% |
106,902
-615
| -0.6% | -$31.9K |
|
2231
United Fire Group
UFCS
$1.41B
| $5.49M | ﹤0.01% |
186,466
-49,342
| -21% | -$1.33M |
|
2232
Portillo's
PTLO
$318M
| $5.49M | ﹤0.01% |
461,376
-886
| -0.2% | -$11.5K |
|
2233
Vitesse Energy
VTS
$662M
| $5.45M | ﹤0.01% |
221,801
+3,883
| +2% | +$99.4K |
|
|
OLO
2234
DELISTED
Olo Inc
OLO
| $5.44M | ﹤0.01% |
901,377
-135,031
| -13% | -$943K |
|
2235
Barclays
BCS
$95B
| $5.41M | ﹤0.01% |
352,328
+43,607
| +14% | +$653K |
|
2236
PDF Solutions
PDFS
$1.92B
| $5.4M | ﹤0.01% |
282,752
+11,920
| +4% | +$293K |
|
2237
Monro
MNRO
$388M
| $5.4M | ﹤0.01% |
373,384
+32,666
| +10% | +$624K |
|
2238
Phibro Animal Health
PAHC
$1.44B
| $5.4M | ﹤0.01% |
252,606
-38,050
| -13% | -$850K |
|
2239
Yext
YEXT
$558M
| $5.39M | ﹤0.01% |
875,751
-167,757
| -16% | -$1.08M |
|
|
ORC
2240
Orchid Island Capital
ORC
$1.28B
| $5.39M | ﹤0.01% |
716,584
+52,929
| +8% | +$435K |
|
2241
Replimune Group
REPL
$1.08B
| $5.38M | ﹤0.01% |
552,046
+43,648
| +9% | +$540K |
|
2242
Smith & Wesson
SWBI
$651M
| $5.38M | ﹤0.01% |
577,072
+40,815
| +8% | +$420K |
|
2243
Horizon Bancorp
HBNC
$1.05B
| $5.35M | ﹤0.01% |
355,013
-4,234
| -1% | -$68.7K |
|
2244
Praxis Precision Medicines
PRAX
$10.3B
| $5.34M | ﹤0.01% |
141,080
-1,812
| -1% | -$113K |
|
2245
First Watch Restaurant Group
FWRG
$768M
| $5.34M | ﹤0.01% |
320,706
+10,855
| +4% | +$209K |
|
|
TRTX
2246
TPG RE Finance Trust
TRTX
$606M
| $5.32M | ﹤0.01% |
652,591
-84,484
| -11% | -$715K |
|
2247
Ceco Environmental
CECO
$4.01B
| $5.3M | ﹤0.01% |
232,536
-4,928
| -2% | -$131K |
|
|
BASE
2248
DELISTED
Couchbase
BASE
| $5.3M | ﹤0.01% |
336,418
-60,281
| -15% | -$999K |
|
2249
Orthofix Medical
OFIX
$432M
| $5.3M | ﹤0.01% |
324,847
-14,684
| -4% | -$258K |
|
|
SNCY
2250
DELISTED
Sun Country Airlines
SNCY
| $5.29M | ﹤0.01% |
429,058
+73,025
| +21% | +$1.13M |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.